Email this article 
Hide
Show all
Case Report
Combined antiretroviral and antituberculosis drug resistance following incarceration
Submitted: 12 December 2013 | Published: 17 September 2013
About the author(s)
Katharine Elizabeth Stott, Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa, South AfricaTulio de Oliveira, Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa; Research Department of Infection, University College London, London, United Kingdom, South Africa
Richard John Lessells, Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom, South Africa
Abstract
We describe a case of HIV/tuberculosis (TB) co-infection from KwaZulu-Natal, South Africa, characterised by drug resistance in both pathogens. The development of drug resistance was linked temporally to two periods of incarceration. This highlights the urgent need for improved integration of HIV/TB control strategies within prison health systems and within the broader public health framework.
Keywords
Metrics
Total abstract views: 4007Total article views: 4408
Crossref Citations
1. Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence
Neesha Rockwood, Frederick Sirgel, Elizabeth Streicher, Robin Warren, Graeme Meintjes, Robert J Wilkinson
The Journal of Infectious Diseases vol: 216 issue: 6 first page: 632 year: 2017
doi: 10.1093/infdis/jix337